Sanofi India stock hits 52-week low amid five-session decline

Published on 10/14/2026 at 01:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sanofi India stock touched a 52-week low on October 13, 2026. Market value stood at INR 68.1 billion, with a high of INR 4,898.00.

Pressure and valuation context

Sanofi India reached a fresh 52-week low on October 13, 2026.
The stock's 52-week range ran from INR 2,907.40 to INR 4,898.00.
Sanofi India's market capitalization stood at INR 68.1 billion on October 13, 2026.

Modern pharmaceutical sterile fill-and-finish manufacturing facility interior with glass vial-filling machines and cleanroom workers in white suits — Sanofi FR0000120578 photorealistic sterile fill-and-finish facility with vial-filling machines and cleanroom workers, Illustration mit AI erstellt.

Sanofi India (ISIN INE058A01010) closed at a fresh 52-week low on October 13, 2026, as MarketsMojo reported. The five-session decline puts the Indian pharmaceutical company at a sharp distance from its yearly peak.

Five sessions end at yearly low

MarketsMojo reported that Sanofi India had closed lower for five consecutive sessions by October 13, 2026, when the stock reached its fresh 52-week low. The report also recorded a 37.71 percent decline over the previous year, while the Sensex had fallen 11.87 percent over the same period.

The comparison points to company-specific pressure rather than a simple market-wide move. MarketsMojo also described the stock as trading below its major moving averages, a technical pattern that reinforces the significance of the new yearly low.

What does the valuation signal?

The market data show a 52-week range of INR 2,907.40 to INR 4,898.00. The range leaves a spread of INR 1,990.60 between the low and high, giving investors a clear measure of how far the stock has moved from its upper boundary.

Sanofi India's market capitalization stood at INR 68.1 billion on October 13, 2026. MarketsMojo also reported a 4.20 percent dividend yield and a 41.70 percent return on equity, creating a mixed picture of falling market value alongside shareholder-return and profitability measures.

Business remains India focused

Sanofi India manufactures and distributes pharmaceutical products across therapeutic areas including diabetes, cardiology, thrombosis, infections and central nervous system treatments. Aditya Trading identifies Sanofi India as listed on the NSE under the SANOFI symbol and assigns ISIN INE058A01010 to the company.

The company also sells products through independent distributors and exports to 24 countries, according to the company profile. That footprint gives the stock a broader operating base, but the October 13, 2026 market move shows that investors are currently placing greater weight on the weak share-price trend.

Stock closes at yearly low

The latest reported home-market close was INR 2,908.15 on October 13, 2026, at the fresh 52-week low. The level stands against a reported 52-week high of INR 4,896.00 in the same market update.

Market context: Market report BSE Sensex.